Comparison of Erector Spinae Plane Block (ESPB) With the Combination of Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) in the Management of Postoperative Sternotomy Pain in Patients Undergoing Cardiac Surgery Via Sternotomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Erector spinae plane block (ESPB): Bilateral ultrasound-guided ESPB is performed at the T4 or T5 vertebral level. Following skin preparation and visualization of the transverse process and erector spinae muscle, a block needle is inserted. After confirming the needle tip position between the muscle and the transverse process, 0.5 mL/kg of 0.25% Bupivacaine is injected on each side.
Superficial Parasternal Intercostal Plane Block (SPIPB): Bilateral ultrasound-guided SPIPB is performed. 0.25% Bupivacaine is administered. This is part of a combined regional analgesia technique for sternotomy.
Serratus Anterior Plane Block (SAPB): Bilateral ultrasound-guided SAPB is performed. 0.25% Bupivacaine is administered. This is part of a combined regional analgesia technique for the chest wall.
Study summary
This study aims to compare the effectiveness of two regional anesthesia techniques in managing pain for participants undergoing cardiac surgery via sternotomy. The investigators will evaluate whether the Erector Spinae Plane Block (ESPB) or a combination of the Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) provides better pain control and recovery outcomes.
Eligibility
Primary outcome measure(s)
- Pain Intensity (Visual Analog Scale Score) — At 0, 1, 2, 4, 8, 12, 16 and 24 hours postoperatively.
Pain levels assessed using the Visual Analog Scale (0 = no pain, 10 = worst imaginable pain).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Bursa Uludag University Hospital | Bursa | Nilüfer | Recruiting |
More Uludag University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07472296 on ClinicalTrials.gov ↗ ← All trials in Turkey